← Back to patent-cliff list

CAS 52-90-4

Plant-derived natural amino-acid L-cysteineL-Cysteine(R)-2-amino-3-mercaptopropanoic acid hydrochloride hydrate

Codes: Reduced Glutathione Sodium-002, Cilastatin Sodium-008, Cysteine

Application context (from source-drug indications)

Acute respiratory distress syndromeReduced Glutathione SodiumLiver diseaseReduced Glutathione Sodium酒精性肝炎Reduced Glutathione Sodium酒精性肝硬化Reduced Glutathione Sodium酒精性脂肪肝病Reduced Glutathione SodiumSepsisReduced Glutathione SodiumInfectious diseaseCilastatin Sodium自闭症谱系障碍Acetylcysteine lysinateCystic fibrosisAcetylcysteine lysinate

Source drugs (routes using this intermediate)

DrugTierExpiry
Reduced Glutathione SodiumTier C — Watch / trade-
Cilastatin SodiumTier C — Watch / trade-
Acetylcysteine lysinateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Reduced Glutathione SodiumOptimised routesteps: 1total yield: 224mg(Reduced Glutathione Sodium (Free))
(S)-(+)-Glutamic acid→Plant-derived natural amino-acid L-cysteine→Aminoethanoic acid
Acetylcysteine lysinateOriginator routesteps: 2total yield: /
(R)-2-amino-3-mercaptopropanoic acid hydrochloride hydrate→Acetylcysteine→L-lysine

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.